查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1648739

2025 年全球药物筛检市场报告

Drug Screening Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年药物筛检市场将快速成长。到 2029 年，这一数字将成长至 171 亿美元，复合年增长率为 15.0%。预测期内的增长可归因于大麻合法化和阿片类药物危机、体育赛事的增加、照护现场和快速检测、不断变化的药物政策和法规、职场健康和保健计划的扩大以及国际市场的扩大。预测期内的关键趋势包括先进的药物检测技术、远端医疗和远端测试、研发投资、创新药物检测套组和设备以及检测技术的进步。

预计药物筛检市场的成长将受到药物和酒精消费量增加的推动。药物成瘾是一种影响大脑和行为的疾病，导致无法控制使用合法或非法物质，如酒精、大麻或尼古丁。随着药物和酒精成瘾的增加，相关的健康风险也在增加，因此需要进行药物筛检。 2022 年，全球对毒品和酒精消费的担忧依然存在，国家药物使用和健康调查 (NSDUH) 报告称，与前一年同期比较， 12 岁及以上美国人的药物使用率增加了 3.8%。此外，21.4% 的该年龄组成员报告在过去一年中使用过非法药物或滥用处方笺药。持续的疫情加剧了毒品风险，某些地区的青少年大麻使用量增加了四倍。药物和酒精消费量的增加对药物筛检市场的成长贡献巨大。

预计未来几年对药物滥用治疗的需求不断增长将推动药物筛检市场的成长。药物滥用是指使用有害物质，其量会对使用者或他人产生不利影响。药物筛检有助于识别体内通常不存在的化合物。这个过程从筛检测试开始，然后进行二次测试以检测和确认特定物质，因此对药物滥用治疗的需求增加将支持市场扩张。例如，根据美国卫生与公共服务部2023年8月发布的报告，美国有超过2,700万人报告近期有非法药物使用或处方药滥用的情况。此外，近四分之一的成年人和青少年承认过去一个月有过狂饮行为。据估计，每年因滥用药物造成的经济损失为：酒精 2,490 亿美元，非法药物 1,930 亿美元。因此，在预测期内，对药物滥用治疗的不断增长的需求正在推动药物筛检市场的成长。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、通膨、地缘政治、新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球药物筛检PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素、限制因素）
  • 最终用途产业分析
  • 全球药物筛检市场成长率分析
  • 全球药物筛检市场表现：规模与成长，2019 年至 2024 年
  • 全球药物筛检市场预测：2024-2029 年及 2034 年规模与成长
  • 全球药物筛检总目标市场 (TAM)

第六章 市场细分

  • 全球药物筛检市场：依产品、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 快速检测装置
  • 耗材
  • 其他产品
  • 全球药物筛检市场（按样本类型、表现和预测），2019-2024 年、2024-2029 年、2034 年
  • 口腔液体样本
  • 头髮样本
  • 尿液样本
  • 呼吸样本
  • 其他样品类型
  • 全球药物筛检市场：按最终用户、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 药物检测实验室
  • 职场
  • 刑事司法和执法
  • 医院
  • 药物治疗中心
  • 个人用户
  • 疼痛管理中心
  • 学校和大学
  • 全球药物筛检市场：快速检测设备细分、类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 尿液药物检测套组
  • 唾液药物检测套组
  • 血液药物检测设备
  • 即时试纸
  • 全球药物筛检市场：耗材细分、类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 试剂和测定
  • 样本采集装置
  • 校准标准
  • 全球药物筛检市场：其他产品细分、按类型、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 实验设备
  • 软体解决方案
  • 储存和运输解决方案

第七章 区域和国家分析

  • 全球药物筛检市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球药物筛检市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第 17 章 德国市场

第 18 章 法国市场

第 19 章：义大利市场

第 20 章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第 25 章：加拿大市场

第26章 南美洲市场

第 27 章：巴西市场

第28章 中东市场

第 29 章：非洲市场

第 30 章竞争格局与公司概况

  • 药物筛检市场：竞争格局
  • 药物筛检市场：公司简介
    • Laboratory Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • OraSure Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Alfa Scientific Designs Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Thermo Fisher Scientific Inc.
  • Dragerwerk AG & Co. KGaA
  • LifeLoc Technologies Inc.
  • MPD Inc.
  • Omega Laboratories Inc.
  • Premier Biotech Inc.
  • Psychemedics Corporation
  • F. Hoffmann-La Roche Ltd.
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • Medtox Scientific Inc.
  • American Screening Corporation
  • Clinical Reference Laboratory Inc.
  • Express Diagnostics International Inc.
  • Global Drug Testing Services

第 32 章 全球竞争基准化分析与仪錶板

第33章 重大併购

第 34 章 近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029 年药物筛检市场 - 提供最多新机会的国家
  • 2029 年药物筛检市场 - 提供最新兴机会的细分市场
  • 药物筛检市场 2029-成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第 36 章 附录

简介目录
Product Code: r21389

Drug screening is an approach used for drug testing, specifically designed and optimized for clinical trials. It involves the analysis of blood, urine, hair, or saliva to detect the presence of chemicals, pollutants, and other illicit substances left in the body due to drug usage.

The main types of drug screening products include rapid testing devices, consumables, and other related items. Rapid testing devices are user-friendly screening tools that provide quicker results compared to traditional laboratory tests. Various samples, such as oral fluid, hair, urine, breath, and others, are used in drug screening. These screenings find applications in drug testing laboratories, workplaces, criminal justice and law enforcement, hospitals, drug treatment centers, individual users, pain management centers, schools, and colleges.

The drug screening market research report is one of a series of new reports from The Business Research Company that provides drug screening market statistics, including drug screening industry global market size, regional shares, competitors with a drug screening market share, detailed drug screening market segments, market trends and opportunities, and any further data you may need to thrive in the drug screening industry. This drug screening market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug screening market size has grown rapidly in recent years. It will grow from $8.57 billion in 2024 to $9.79 billion in 2025 at a compound annual growth rate (CAGR) of 14.2%. The growth in the historic period can be attributed to pharmaceutical drug testing, healthcare and clinical diagnostics, substance abuse treatment, research and development investments, and increasing use of drug testing kits and devices.

The drug screening market size is expected to see rapid growth in the next few years. It will grow to $17.1 billion in 2029 at a compound annual growth rate (CAGR) of 15.0%. The growth in the forecast period can be attributed to legalization of cannabis and opioid crisis, increasing sports events, point-of-care and rapid testing, evolving drug policies and regulations, growing workplace wellness and health programs, and international market expansion. Major trends in the forecast period include advanced drug detection technologies, telemedicine and remote testing, research and development investments, innovative drug testing kits and devices, and technological advancements in testing.

The growth of the drug screening market is expected to be driven by the increasing prevalence of drug and alcohol consumption. Drug addiction, a condition affecting both brain and behavior, leads to the inability to control the use of legal or illegal substances such as alcohol, marijuana, and nicotine. As drug and alcohol addiction rise, the associated health risks also increase, necessitating the demand for drug screening. In 2022, global concerns about drug and alcohol consumption persisted, with the National Survey on Drug Use and Health (NSDUH) reporting a 3.8% year-over-year increase in drug use among Americans aged 12 and over. The report also highlighted that 21.4% of people in the same age group had used illegal drugs or misused prescription drugs in the past year. The ongoing pandemic further exacerbated drug risks, with youth cannabis intake increasing up to four times in certain regions. The escalating drug and alcohol consumption significantly contribute to the growth of the drug screening market.

The increasing demand for substance abuse treatment is expected to drive the growth of the drug screening market in the future. Substance abuse refers to the harmful use of a substance in quantities that negatively affect the user or others. Drug screening helps identify compounds that are typically not present in the body. The process begins with a screening test, which is followed by a secondary test to detect and/or confirm the presence of specific substances, so the growing demand for drug abuse treatment will support market expansion. For example, in August 2023, a report from the U.S. Department of Health and Human Services indicated that over 27 million people in the United States had recently reported using illicit drugs or misusing prescription medications. Furthermore, nearly a quarter of both adults and adolescents admitted to binge drinking in the past month. The annual economic cost of substance misuse is estimated at $249 billion for alcohol and $193 billion for illicit drugs. Therefore, the rising need for substance abuse treatment is propelling the growth of the drug screening market during the forecast period.

A notable trend in the drug screening market is the launch of innovative products. Major companies in this sector are actively developing and introducing innovative products to meet the rapidly growing industry demand and enhance their market positions. The COVID-19 pandemic prompted a shift in drug screening approaches, fostering innovation and new product development. Companies are striving to create more effective and widely applicable drug tests for laboratory use. For example, in September 2022, Sysmex Corporation, a Japan-based healthcare company, launched the UF-1500 Fully Automated Urine Particle Testing Analyzer. This innovative product, designed for urine sediment testing and screening, inherits the functionality and usability of the UF-5000 Fully Automated Urine Particle Analyzer while achieving a downsizing of the former model, exemplifying the trend of innovative product launches in the drug screening market.

Companies in the drug screening market are increasingly turning their attention to strategic partnerships and collaborations as a means to enhance their financial strength, fortify their product portfolios, and extend their geographical reach. Strategic collaborations involve agreements between two or more parties to jointly pursue agreed-upon objectives while maintaining their independence as organizations. An illustrative example occurred in December 2022 when PhoreMost Ltd., a UK-based biopharmaceutical company, and ThinkCyte K.K., a Japan-based biotechnology company, announced a strategic research partnership focused on advancing modern phenotypic drug screening through the application of artificial intelligence (AI). This collaboration integrates PhoreMost's SITESEEKER platform, designed to identify optimal new targets for future therapies, with ThinkCyte's Ghost Cytometry technology-a platform leveraging AI for cell characterization and sorting. By combining these innovative technologies, the partnership aims to improve the efficiency and effectiveness of phenotypic drug screening. The collaboration has the potential to identify novel drug targets and facilitate the development of effective therapeutics by leveraging AI and machine learning.

In April 2022, Saladax Biomedical, Inc., a US-based company specializing in the development, manufacturing, and marketing of assays providing rapid therapeutic drug levels, acquired a patent portfolio for antipsychotic drug testing and screening from Janssen Pharmaceutica NV, a Belgium-based pharmaceutical company. This acquisition enabled Saladax to develop tests compatible with chemistry analyzers commonly found in hospitals and a point-of-care instrument suitable for settings where centralized testing is not feasible. These tests address a significant unmet clinical need for patients with serious mental illness (SMI) by delivering rapid and actionable results to healthcare professionals. The collaboration exemplifies how strategic acquisitions contribute to addressing clinical needs and expanding the offerings in the drug screening market.

Major companies operating in the drug screening market include Laboratory Corporation, Quest Diagnostics Incorporated, OraSure Technologies Inc., Alfa Scientific Designs Inc., Abbott Laboratories, Thermo Fisher Scientific Inc., Dragerwerk AG & Co. KGaA, LifeLoc Technologies Inc., MPD Inc., Omega Laboratories Inc., Premier Biotech Inc., Psychemedics Corporation, F. Hoffmann-La Roche Ltd., Shimadzu Corporation, Siemens Healthineers AG, Medtox Scientific Inc., American Screening Corporation, Clinical Reference Laboratory Inc., Express Diagnostics International Inc., Global Drug Testing Services, Kroll Laboratory Specialists Inc., Medscreen Laboratories, National Screening Centers Inc., American Bio Medica Corporation, Mayo Clinic Laboratories, ACM Global Laboratories, Intertek Group plc, Eurofins Scientific SE

North America was the largest region in the drug screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the drug screening market during the forecast period. The regions covered in the drug screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the drug screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

The drug screening market consists of sales of testing kits, reagents, and other supplies. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug Screening Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug screening market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug screening ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drug screening market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Products: Rapid Testing Devices; Consumables; Other Products
  • 2) By Sample Type: Oral Fluid Sample; Hair Sample; Urine Sample; Breath Sample; Other Sample Types
  • 3) By End User: Drug Testing Laboratories; Workplaces; Criminal Justice and Law Enforcement Agencies; Hospitals; Drug Treatment Centers; Individual Users; Pain Management Centers; Schools and Colleges
  • Subsegments:
  • 1) By Rapid Testing Devices: Urine Drug Test Kits; Saliva Drug Test Kits; Blood Drug Test Devices; Instant Test Strips
  • 2) By Consumables: Reagents and Assays; Sample Collection Devices; Calibration Standards
  • 3) By Other Products: Laboratory Equipment; Software Solutions; Storage and Transport Solutions
  • Companies Mentioned: Laboratory Corporation; Quest Diagnostics Incorporated; OraSure Technologies Inc.; Alfa Scientific Designs Inc.; Abbott Laboratories
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Drug Screening Market Characteristics

3. Drug Screening Market Trends And Strategies

4. Drug Screening Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Drug Screening Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Drug Screening PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Drug Screening Market Growth Rate Analysis
  • 5.4. Global Drug Screening Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Drug Screening Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Drug Screening Total Addressable Market (TAM)

6. Drug Screening Market Segmentation

  • 6.1. Global Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Rapid Testing Devices
  • Consumables
  • Other Products
  • 6.2. Global Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral Fluid Sample
  • Hair Sample
  • Urine Sample
  • Breath Sample
  • Other Sample Types
  • 6.3. Global Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug Testing Laboratories
  • Workplaces
  • Criminal Justice and Law Enforcement Agencies
  • Hospitals
  • Drug Treatment Centers
  • Individual Users
  • Pain Management Centers
  • Schools and Colleges
  • 6.4. Global Drug Screening Market, Sub-Segmentation Of Rapid Testing Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Urine Drug Test Kits
  • Saliva Drug Test Kits
  • Blood Drug Test Devices
  • Instant Test Strips
  • 6.5. Global Drug Screening Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Reagents and Assays
  • Sample Collection Devices
  • Calibration Standards
  • 6.6. Global Drug Screening Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Laboratory Equipment
  • Software Solutions
  • Storage and Transport Solutions

7. Drug Screening Market Regional And Country Analysis

  • 7.1. Global Drug Screening Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Drug Screening Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Drug Screening Market

  • 8.1. Asia-Pacific Drug Screening Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Drug Screening Market

  • 9.1. China Drug Screening Market Overview
  • 9.2. China Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Drug Screening Market

  • 10.1. India Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Drug Screening Market

  • 11.1. Japan Drug Screening Market Overview
  • 11.2. Japan Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Drug Screening Market

  • 12.1. Australia Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Drug Screening Market

  • 13.1. Indonesia Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Drug Screening Market

  • 14.1. South Korea Drug Screening Market Overview
  • 14.2. South Korea Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Drug Screening Market

  • 15.1. Western Europe Drug Screening Market Overview
  • 15.2. Western Europe Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Drug Screening Market

  • 16.1. UK Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Drug Screening Market

  • 17.1. Germany Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Drug Screening Market

  • 18.1. France Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Drug Screening Market

  • 19.1. Italy Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Drug Screening Market

  • 20.1. Spain Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Drug Screening Market

  • 21.1. Eastern Europe Drug Screening Market Overview
  • 21.2. Eastern Europe Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Drug Screening Market

  • 22.1. Russia Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Drug Screening Market

  • 23.1. North America Drug Screening Market Overview
  • 23.2. North America Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Drug Screening Market

  • 24.1. USA Drug Screening Market Overview
  • 24.2. USA Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Drug Screening Market

  • 25.1. Canada Drug Screening Market Overview
  • 25.2. Canada Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Drug Screening Market

  • 26.1. South America Drug Screening Market Overview
  • 26.2. South America Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Drug Screening Market

  • 27.1. Brazil Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Drug Screening Market

  • 28.1. Middle East Drug Screening Market Overview
  • 28.2. Middle East Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Drug Screening Market

  • 29.1. Africa Drug Screening Market Overview
  • 29.2. Africa Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Drug Screening Market Competitive Landscape And Company Profiles

  • 30.1. Drug Screening Market Competitive Landscape
  • 30.2. Drug Screening Market Company Profiles
    • 30.2.1. Laboratory Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. OraSure Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Alfa Scientific Designs Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

31. Drug Screening Market Other Major And Innovative Companies

  • 31.1. Thermo Fisher Scientific Inc.
  • 31.2. Dragerwerk AG & Co. KGaA
  • 31.3. LifeLoc Technologies Inc.
  • 31.4. MPD Inc.
  • 31.5. Omega Laboratories Inc.
  • 31.6. Premier Biotech Inc.
  • 31.7. Psychemedics Corporation
  • 31.8. F. Hoffmann-La Roche Ltd.
  • 31.9. Shimadzu Corporation
  • 31.10. Siemens Healthineers AG
  • 31.11. Medtox Scientific Inc.
  • 31.12. American Screening Corporation
  • 31.13. Clinical Reference Laboratory Inc.
  • 31.14. Express Diagnostics International Inc.
  • 31.15. Global Drug Testing Services

32. Global Drug Screening Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Drug Screening Market

34. Recent Developments In The Drug Screening Market

35. Drug Screening Market High Potential Countries, Segments and Strategies

  • 35.1 Drug Screening Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Drug Screening Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Drug Screening Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer